FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy

Lin, JZ; Wang, WW; Hu, TT; Zhu, GY; Li, LN; Zhang, CY; Xu, Z; Yu, HB; Wu, HF; Zhu, JG

Lin, JZ (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Urol, Nanjing 210019, Jiangsu, Peoples R China.; Zhu, JG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing 210006, Jiangsu, Peoples R China.

CANCER LETTERS, 2020; 469 (): 481

Abstract

Docetaxel-mediated chemotherapy is the first line therapy for metastatic castration-resistant prostate cancer (CRPC) patients, but its therapeutic ben......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索